MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABOS — Acumen Pharmaceuticals, Inc. Common Stock
NasdaqAcumen Pharmaceuticals, Inc. Common Stock
$2.07
-0.15(-6.76%)
- O
- 2.22
- H
- 2.29
- L
- 2.07
- V
- 832.15K
⏱️ End-of-day dataAs of Oct 1, 2026
ABOS — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $51.80M | $53.99M | $46.83M | $36.81M | $30.16M | $35.63M |
| Other Short Term Investments | $76.60M | $62.88M | $79.78M | $10.66M | $11.90M | $13.59M |
| Other Receivables | 772,000.00 | 625,000.00 | 379,000.00 | 315,000.00 | 376,000.00 | 345,000.00 |
| Prepaid Assets | 350,000.00 | 601,000.00 | 703,000.00 | 169,000.00 | 481,000.00 | $1.02M |
| Other Current Assets | $3.57M | $4.16M | $4.46M | $4.55M | $4.94M | $5.33M |
| Total Current Assets | $13.31M | $12.23M | $13.22M | $14.84M | $15.49M | $17.83M |
| Properties | 197,000.00 | 243,000.00 | 288,000.00 | 335,000.00 | 373,000.00 | 339,000.00 |
| Goodwill | 24,000.00 | 29,000.00 | 30,000.00 | 50,000.00 | 56,000.00 | 75,000.00 |
| Intangible Assets | 24,000.00 | 29,000.00 | 30,000.00 | 50,000.00 | 56,000.00 | 75,000.00 |
| Other Non Current Assets | 314,000.00 | 309,000.00 | 307,000.00 | 311,000.00 | 307,000.00 | 295,000.00 |
| Total Non Current Assets | 535,000.00 | 581,000.00 | $10.07M | $23.49M | $49.53M | $60.69M |
| Total Assets | $13.36M | $12.28M | $14.22M | $17.19M | $20.45M | $23.90M |
| Accounts Payable | $1.66M | 554,000.00 | 682,000.00 | $2.10M | $1.06M | $5.65M |
| Accrued Expenses | $11.62M | $16.29M | $12.80M | $20.61M | $16.83M | $17.39M |
| Short Term Debt | $14.24M | $8.91M | $3.74M | 142,000.00 | 138,000.00 | 133,000.00 |
| Pensions | $1.22M | $4.07M | $4.37M | $1.84M | 873,000.00 | $4.21M |
| Other Current Liabilities | 497,000.00 | 180,000.00 | 352,000.00 | 161,000.00 | 418,000.00 | 230,000.00 |
| Total Current Liabilities | $29.23M | $30.01M | $21.96M | $24.86M | $19.32M | $27.61M |
| Long Term Debt | $16.92M | $22.40M | $27.09M | $29.96M | $28.86M | $28.60M |
| Total Non Current Liabilities | $16.92M | $22.40M | $27.09M | $29.96M | $29.64M | $29.57M |
| Total Liabilities | $46.15M | $52.40M | $49.05M | $54.82M | $48.96M | $57.18M |
| Common Stock | 7,000.00 | 6,000.00 | 6,000.00 | 6,000.00 | 6,000.00 | 6,000.00 |
| Retained Earnings | $-46.72M | $-44.65M | $-42.13M | $-39.49M | $-35.39M | $-32.51M |
| Other Shareholders Equity | 21,000.00 | 83,000.00 | 109,000.00 | 23,000.00 | 15,000.00 | -48,000.00 |
| Total Shareholders Equity | $87.48M | $70.43M | $93.17M | $11.71M | $15.55M | $18.18M |
| Additional Paid In Capital | $55.46M | $51.68M | $51.44M | $51.19M | $50.94M | $50.70M |
| Investments And Advances | N/A | 0.00 | $9.44M | $22.80M | $48.80M | $59.97M |
| Derivative Product Liabilities | N/A | N/A | N/A | N/A | 780,000.00 | 970,000.00 |